Trial intelligence / Profile preview

Montelukast in Acute Coronary Syndrome

NCT00351364Phase 4Terminated

Sponsor
University of Calgary
Start
Jul 2006
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of montelukast in acute coronary syndrome (ACS), sponsored by University of Calgary. Started Jul 2006; status: terminated.

02

Drugs

montelukast
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT00351364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00351364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call